Class IITerminatedD-0089-2019
Drug recall · October 31, 2018
Alprostadil 500 mcg/mL Injectable recall
Why: Incorrect Product Formulation
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Alprostadil 500 mcg/mL Injectable, Vials, Westlab Pharmacy, Inc., Gainesville, FL 32607 NDC 10002-7335-00
- Lots / codes
Lot: 03192018@42 Discard after 9/15/2018
- Quantity
- 80 syringes
- Company
- Westlab Pharmacy, Inc. dba Westlab Pharmacy, Gainesville, FL
- Distribution
- Nationwide
- Initiated
- August 10, 2018 · Voluntary: Firm initiated
- Classified
- October 24, 2018
- Reported
- October 31, 2018
- Ended
- May 7, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Alprostadil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.